Inventor · disambiguated record
Laurence Harbige
Also filed as: HARBIGE LAURENCE · HARBIGE LAURENCE S
11 granted patents·8 pending applications·48 citations·filing 2004–2016
88Inventor score
Top patents by PatentIndex Score
19 records- 0182US8691818B2Cyclic triazo and diazo sodium channel blockersLEACH MICHAEL·Filed 2009·Granted Apr 8, 2014·6 cites·7 claims
- 0281US8268823B2Medical use of triazine derivativesLEACH MICHAEL·Filed 2007·Granted Sep 18, 2012·6 cites·4 claims
- 0381US7935729B2Use of triglyceride oils containing γ-linolenic acid residues and linoleic acid residues for the treatment of neurodegenerative diseaseBTG INT LTD·Filed 2004·Granted May 3, 2011·18 cites·34 claims
- 0480US8748599B2Cyclic triazo sodium channel blockersLEACH MICHAEL·Filed 2010·Granted Jun 10, 2014·5 cites·18 claims
- 0579US8748600B2Cyclic triazo sodium channel blockersLEACH MICHAEL·Filed 2010·Granted Jun 10, 2014·6 cites·24 claims
- 0677US9000155B2Cyclic triazo sodium channel blockersUNIV GREENWICH·Filed 2014·Granted Apr 7, 2015·3 cites·21 claims
- 0774US10576086B2Triazine derivatives as interferon-gamma inhibitorsUNIV GREENWICH·Filed 2016·Granted Mar 3, 2020·2 cites·18 claims
- 0872US9862691B2Cyclic triazo and diazo sodium channel blockersUNIV GREENWICH·Filed 2016·Granted Jan 9, 2018·1 cites·20 claims
- 0970US9422253B2Cyclic triazo and diazo sodium channel blockersUNIV GREENWICH·Filed 2014·Granted Aug 23, 2016·1 cites·14 claims
- 1065US2010113810A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2009·Application pending·0 cites
- 1157US7964641B2Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2004·Granted Jun 21, 2011·0 cites·4 claims
- 1250US2004229873A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2004·Application pending·0 cites
- 1347US2012142775A1Treatment of neurodegenerative conditionsHARBIGE LAURENCE S·Filed 2012·Application pending·0 cites
- 1447US2013005732A1New medical use of triazine derivativesUNIV GREENWICH·Filed 2012·Application pending·0 cites
- 1543US2009023807A1Treatment of Cytokine Dysregulation by Using Sn-2 Gamma-Linolenoyl, Gamma-Diho-Molinolenoyl or Arachidonoyl Patty Acid Glycerol MonoestersBTG INT LTD·Filed 2006·Application pending·0 cites
- 1642US2011184063A1Treatment of neurodegenerative conditionsBTG INT LTD·Filed 2011·Application pending·0 cites
- 1740US2009137660A1Cytokine Modulators Using Cyclic Glycerides of Essential Polyunsaturated Fatty AcidsHARBIGE LAURENCE S·Filed 2006·Application pending·0 cites
- 1840US2009036410A1Structured PhospholipidsBTG INT LTD·Filed 2005·Application pending·0 cites
- 1938US8114903B2Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acidsHARBIGE LAURENCE S·Filed 2010·Granted Feb 14, 2012·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Laurence Harbige files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →